BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17998911)

  • 1. Use of nanocarriers for transdermal vaccine delivery.
    Lawson LB; Freytag LC; Clements JD
    Clin Pharmacol Ther; 2007 Dec; 82(6):641-3. PubMed ID: 17998911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential use of nanoparticles for transcutaneous vaccine delivery: effect of particle size and charge.
    Kohli AK; Alpar HO
    Int J Pharm; 2004 May; 275(1-2):13-7. PubMed ID: 15081134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The design of polymer-based nanocarriers for effective transdermal delivery.
    Kim J; Shim J; Kim YJ; Char K; Suh KD; Kim JW
    Macromol Biosci; 2010 Oct; 10(10):1171-6. PubMed ID: 20552607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human skin penetration and distribution of nimesulide from hydrophilic gels containing nanocarriers.
    Alves MP; Scarrone AL; Santos M; Pohlmann AR; Guterres SS
    Int J Pharm; 2007 Aug; 341(1-2):215-20. PubMed ID: 17482392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentials of new nanocarriers for dermal and transdermal drug delivery.
    Neubert RH
    Eur J Pharm Biopharm; 2011 Jan; 77(1):1-2. PubMed ID: 21111043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current view on nanosized solid lipid carriers for drug delivery to the skin.
    Kristl J; Teskac K; Grabnar PA
    J Biomed Nanotechnol; 2010 Oct; 6(5):529-42. PubMed ID: 21329046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transdermal drug delivery: from micro to nano.
    Pegoraro C; MacNeil S; Battaglia G
    Nanoscale; 2012 Mar; 4(6):1881-94. PubMed ID: 22334401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcutaneous vaccines: novel advances in technology and delivery for overcoming the barriers.
    Li N; Peng LH; Chen X; Nakagawa S; Gao JQ
    Vaccine; 2011 Aug; 29(37):6179-90. PubMed ID: 21740946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticles as carriers for nasal vaccine delivery.
    Köping-Höggård M; Sánchez A; Alonso MJ
    Expert Rev Vaccines; 2005 Apr; 4(2):185-96. PubMed ID: 15889992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dry-coated microprojection array patches for targeted delivery of immunotherapeutics to the skin.
    Chen X; Prow TW; Crichton ML; Jenkins DW; Roberts MS; Frazer IH; Fernando GJ; Kendall MA
    J Control Release; 2009 Nov; 139(3):212-20. PubMed ID: 19577597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using the method of homogenization to calculate the effective diffusivity of the stratum corneum with permeable corneocytes.
    Rim JE; Pinsky PM; van Osdol WW
    J Biomech; 2008; 41(4):788-96. PubMed ID: 18093598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfollicular delivery takes root: the future for vaccine design?
    Hansen S; Lehr CM
    Expert Rev Vaccines; 2014 Jan; 13(1):5-7. PubMed ID: 24428204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing microneedle arrays to increase skin permeability for transdermal drug delivery.
    Al-Qallaf B; Das DB
    Ann N Y Acad Sci; 2009 Apr; 1161():83-94. PubMed ID: 19426308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current status and future potential of transdermal drug delivery.
    Prausnitz MR; Mitragotri S; Langer R
    Nat Rev Drug Discov; 2004 Feb; 3(2):115-24. PubMed ID: 15040576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erbium:YAG laser enhances transdermal peptide delivery and skin vaccination.
    Lee WR; Pan TL; Wang PW; Zhuo RZ; Huang CM; Fang JY
    J Control Release; 2008 Jun; 128(3):200-8. PubMed ID: 18471920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dry coating of immunotherapeutics to densely packed and short microprojection arrays.
    Park K
    J Control Release; 2009 Nov; 139(3):171. PubMed ID: 19735682
    [No Abstract]   [Full Text] [Related]  

  • 17. Transcutaneous immunization: an overview of advantages, disease targets, vaccines, and delivery technologies.
    Karande P; Mitragotri S
    Annu Rev Chem Biomol Eng; 2010; 1():175-201. PubMed ID: 22432578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transdermal drug delivery systems: skin perturbation devices.
    Brown MB; Traynor MJ; Martin GP; Akomeah FK
    Methods Mol Biol; 2008; 437():119-39. PubMed ID: 18369965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanovaccines : nanocarriers for antigen delivery.
    Gonzalez-Aramundiz JV; Cordeiro AS; Csaba N; de la Fuente M; Alonso MJ
    Biol Aujourdhui; 2012; 206(4):249-61. PubMed ID: 23419252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Needle-free delivery of macromolecules through the skin using controllable jet injectors.
    Hogan NC; Taberner AJ; Jones LA; Hunter IW
    Expert Opin Drug Deliv; 2015; 12(10):1637-48. PubMed ID: 26004884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.